دورية أكاديمية

Radiotracers for Imaging of Fibrosis : Advances during the Last Two Decades and Future Directions

التفاصيل البيبلوغرافية
العنوان: Radiotracers for Imaging of Fibrosis : Advances during the Last Two Decades and Future Directions
المؤلفون: Eriksson, Olof, Velikyan, Irina
بيانات النشر: Uppsala universitet, Science for Life Laboratory, SciLifeLab
Uppsala universitet, Translationell avbildning med PET
Uppsala universitet, Institutionen för kirurgiska vetenskaper
Antaros Tracer AB, Dragarbrunnsgatan 46,2 Tr, S-75320 Uppsala, Sweden.
سنة النشر: 2023
المجموعة: Uppsala University: Publications (DiVA)
مصطلحات موضوعية: fibrosis, fibrogenesis, fibrolysis, radiochemistry, collagen, positron emission tomography, molecular imaging, Radiology, Nuclear Medicine and Medical Imaging, Radiologi och bildbehandling, Cancer and Oncology, Cancer och onkologi
الوصف: Fibrosis accompanies various pathologies, and there is thus an unmet medical need for non-invasive, sensitive, and quantitative methods for the assessment of fibrotic processes. Currently, needle biopsy with subsequent histological analysis is routinely used for the diagnosis along with morphological imaging techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US). However, none of these imaging techniques are sufficiently sensitive and accurate to detect minor changes in fibrosis. More importantly, they do not provide information on fibrotic activity on the molecular level, which is critical for fundamental understanding of the underlying biology and disease course. Molecular imaging technology using positron emission tomography (PET) offers the possibility of imaging not only physiological real-time activity, but also high-sensitivity and accurate quantification. This diagnostic tool is well established in oncology and has exhibited exponential development during the last two decades. However, PET diagnostics has only recently been widely applied in the area of fibrosis. This review presents the progress of development of radiopharmaceuticals for non-invasive detection of fibrotic processes, including the fibrotic scar itself, the deposition of new fibrotic components (fibrogenesis), or the degradation of existing fibrosis (fibrolysis).
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: Pharmaceuticals, 2023, 16:11; orcid:0000-0002-2515-8790; orcid:0000-0002-3732-8857; http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-519299Test; PMID 38004406; ISI:001119898000001
DOI: 10.3390/ph16111540
الإتاحة: https://doi.org/10.3390/ph16111540Test
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-519299Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.FBC14B89
قاعدة البيانات: BASE